Loring Wolcott & Coolidge Fiduciary Advisors’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,300
| Closed | -$5.6K | – | 548 |
|
|
2025
Q2 | $5.6K | Hold |
1,300
| – | – | ﹤0.01% | 494 |
|
|
2025
Q1 | $6.93K | Hold |
1,300
| – | – | ﹤0.01% | 497 |
|
|
2024
Q4 | $6.04K | Hold |
1,300
| – | – | ﹤0.01% | 505 |
|
|
2024
Q3 | $6.41K | Hold |
1,300
| – | – | ﹤0.01% | 513 |
|
|
2024
Q2 | $6.24K | Hold |
1,300
| – | – | ﹤0.01% | 512 |
|
|
2024
Q1 | $5.88K | Hold |
1,300
| – | – | ﹤0.01% | 520 |
|
|
2023
Q4 | $4.03K | Hold |
1,300
| – | – | ﹤0.01% | 526 |
|
|
2023
Q3 | $6.77K | Hold |
1,300
| – | – | ﹤0.01% | 533 |
|
|
2023
Q2 | $12K | Hold |
1,300
| – | – | ﹤0.01% | 534 |
|
|
2023
Q1 | $10.7K | Hold |
1,300
| – | – | ﹤0.01% | 510 |
|
|
2022
Q4 | $14.5K | Hold |
1,300
| – | – | ﹤0.01% | 483 |
|
|
2022
Q3 | $15K | Hold |
1,300
| – | – | ﹤0.01% | 504 |
|
|
2022
Q2 | $20K | Hold |
1,300
| – | – | ﹤0.01% | 503 |
|
|
2022
Q1 | $27K | Hold |
1,300
| – | – | ﹤0.01% | 496 |
|
|
2021
Q4 | $31K | Hold |
1,300
| – | – | ﹤0.01% | 500 |
|
|
2021
Q3 | $26K | Sell |
1,300
-128
| -9% | -$2.62K | ﹤0.01% | 511 |
|
|
2021
Q2 | $29K | Buy |
+1,428
| New | +$30.5K | ﹤0.01% | 510 |
|
|
2021
Q1 | – | Sell |
-1,300
| Closed | -$28K | – | 548 |
|
|
2020
Q4 | $28K | Hold |
1,300
| – | – | ﹤0.01% | 481 |
|
|
2020
Q3 | $23K | Hold |
1,300
| – | – | ﹤0.01% | 456 |
|
|
2020
Q2 | $24K | Hold |
1,300
| – | – | ﹤0.01% | 428 |
|
|
2020
Q1 | $22K | Hold |
1,300
| – | – | ﹤0.01% | 455 |
|
|
2019
Q4 | $27K | Hold |
1,300
| – | – | ﹤0.01% | 497 |
|
|
2019
Q3 | $25K | Hold |
1,300
| – | – | ﹤0.01% | 493 |
|
|
2019
Q2 | $23K | Hold |
1,300
| – | – | ﹤0.01% | 498 |
|
|
2019
Q1 | $24K | Hold |
1,300
| – | – | ﹤0.01% | 503 |
|
|
2018
Q4 | $21K | Hold |
1,300
| – | – | ﹤0.01% | 517 |
|
|
2018
Q3 | $19K | Hold |
1,300
| – | – | ﹤0.01% | 498 |
|
|
2018
Q2 | $18K | Hold |
1,300
| – | – | ﹤0.01% | 510 |
|
|
2018
Q1 | $17K | Hold |
1,300
| – | – | ﹤0.01% | 551 |
|
|
2017
Q4 | $18K | Sell |
1,300
-72
| -5% | -$973 | ﹤0.01% | 529 |
|
|
2017
Q3 | $18K | Buy |
1,372
+72
| +6% | +$927 | ﹤0.01% | 517 |
|
|
2017
Q2 | $17K | Hold |
1,300
| – | – | ﹤0.01% | 508 |
|
|
2017
Q1 | $17K | Hold |
1,300
| – | – | ﹤0.01% | 507 |
|
|
2016
Q4 | $16K | Hold |
1,300
| – | – | ﹤0.01% | 488 |
|
|
2016
Q3 | $19K | Hold |
1,300
| – | – | ﹤0.01% | 484 |
|
|
2016
Q2 | $20K | Hold |
1,300
| – | – | ﹤0.01% | 484 |
|
|
2016
Q1 | $17K | Sell |
1,300
-1,100
| -46% | -$12.5K | ﹤0.01% | 494 |
|
|
2015
Q4 | $28K | Buy |
2,400
+1,100
| +85% | +$12.6K | ﹤0.01% | 484 |
|
|
2015
Q3 | $17K | Hold |
1,300
| – | – | ﹤0.01% | 500 |
|
|
2015
Q2 | $17K | Hold |
1,300
| – | – | ﹤0.01% | 500 |
|
|
2015
Q1 | $19K | Hold |
1,300
| – | – | ﹤0.01% | 511 |
|
|
2014
Q4 | $18K | Hold |
1,300
| – | – | ﹤0.01% | 508 |
|
|
2014
Q3 | $16K | Buy |
+1,300
| New | +$17.3K | ﹤0.01% | 491 |
|
Other funds holding MPT
Loring Wolcott & Coolidge Fiduciary Advisors's MPT Position: Q3 2025 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Medical Properties Trust (MPT) in Q3 2025, closing a stake of 1,300 shares — an estimated $5.6K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MPT in Q3 2014 and held it in 43 quarters. The position peaked at $31K in Q4 2021. 462 funds tracked by Wall St. Rank hold MPT as of Q3 2025.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Medical Properties Trust position as of Q3 2025 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 1,300 Medical Properties Trust shares in Q3 2025, an estimated $5.6K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Medical Properties Trust in Q3 2014 and held it in 43 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Medical Properties Trust position peaked at $31K in Q4 2021.
- 462 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2025.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.